Cargando…
Optimization of lead compounds into on-demand, nonhormonal contraceptives: leveraging a public–private drug discovery institute collaboration(†)
Efforts to develop new male or female nonhormonal, orally available contraceptives assume that to be effective and safe, targets must be (1) essential for fertility; (2) amenable to targeting by small-molecule inhibitors; and (3) restricted to the germline. In this perspective, we question the third...
Autores principales: | Balbach, Melanie, Fushimi, Makoto, Huggins, David J, Steegborn, Clemens, Meinke, Peter T, Levin, Lonny R, Buck, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401349/ https://www.ncbi.nlm.nih.gov/pubmed/32307523 http://dx.doi.org/10.1093/biolre/ioaa052 |
Ejemplares similares
-
On-demand male contraception via acute inhibition of soluble adenylyl cyclase
por: Balbach, Melanie, et al.
Publicado: (2023) -
Systemic hormonal contraception and risk of venous thromboembolism
por: Heikinheimo, Oskari, et al.
Publicado: (2022) -
Telehealth for Contraceptive Services During the COVID-19 Pandemic: Provider Perspectives
por: Rao, Lavanya, et al.
Publicado: (2022) -
Contraceptive use among women seeking an early induced abortion in Sweden
por: Niemeyer Hultstrand, Jenny, et al.
Publicado: (2023) -
Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial
por: Haverinen, Annina H., et al.
Publicado: (2022)